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The balance of quiescence and cell division is critical for tissue homeostasis and organismal health. Serum stimulation
of fibroblasts is well studied as a classic model of entry into the cell division cycle, but the induction of cellular
quiescence, such as by serum deprivation (SD), is much less understood. Here we show that SS and SD activate distinct
early transcriptional responses genome-wide that converge on a late symmetric transcriptional program. Several
serum deprivation early response genes (SDERGs), including the putative tumor suppressor genes SALL2 and MXI1, are
required for cessation of DNA synthesis in response to SD and induction of additional SD genes. SDERGs are
coordinately repressed in many types of human cancers compared to their normal counterparts, and repression of
SDERGs predicts increased risk of cancer progression and death in human breast cancers. These results identify a gene
expression program uniquely responsive to loss of growth factor signaling; members of SDERGs may constitute novel
growth inhibitors that prevent cancer.
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Introduction
Quiescence, also termed G0, is deﬁned as reversible cell
cycle arrest where cells are poised to re-enter the cell cycle.
Most eukaryotic cells spend the majority of their lifespan in
the state of quiescence. In response to injury or speciﬁc
extracellular stimuli, many types of somatic cells can quickly
leave the quiescent state and enter the cell division cycle. For
instance, in the skin, dermal ﬁbroblasts and hair follicle stem
cells are for the most part quiescent [1,2]. Injury to the skin
stimulates ﬁbroblasts and epidermal stem cells to rapidly
proliferate; once tissue repair has been accomplished, the
cells exit the cell cycle and reenter quiescence. Similarly,
memory lymphocytes are quiescent as they circulate and
survey the body, dividing only when stimulated by cognate
antigenic stimuli to mount an immune response [3]. In
addition to the absence of cell division, quiescent cells exhibit
systematic differences in their metabolism and propensity for
differentiation, which may help to ensure the reversibility of
quiescence [4]. The ubiquity of quiescence as a central feature
of cell life suggests that its regulation may be critical to
normal development, degenerative diseases, and cancer
[1,3,4].
Serum, the soluble fraction of clotted blood, is an
important mitogenic signal in wound healing and tissue
homeostasis. Many key genes involved in cell cycle entry were
initially identiﬁed by their unique temporal patterns of
expression in response to serum stimulation (SS) and are
dysregulated in cancer [5]. In addition to cell cycle entry,
serum induces a transcriptional program activating many
aspects of wound healing [6]. This wound response program is
recapitulated in many human cancers and is a strong
predictor of tumor progression for these cancers [7,8]. While
much is known about the signal transduction pathways,
transcription factors, and immediate early genes that mediate
the exit from quiescence and entry to the cell division cycle
[5,6,9,10], comparatively much less is known about the
mechanisms by which cells enter the quiescent state. Growth
factor deprivation, contact inhibition, and loss of adhesion
can each induce a shared set of quiescence genes [4],
indicating the potential existence of multiple pathways to
quiescence. Several tumor suppressor genes, such as Rb and
PTEN, are required for quiescence maintenance in low serum
conditions [11–13]. Yamamoto and colleagues have identiﬁed
a set of antiproliferative genes whose repression requires
ongoing activity of the mitogen-responsive kinase ERK
during cell cycle progression [10]. The induction of these
genes during quiescence is therefore simply a consequence of
the absence of mitogen-induced signaling. If this mode of
balanced regulation were generally applicable, then one
might predict a symmetric network of gene regulation during
quiescence entry and exit. Alternatively, an inducer of
quiescence may engage a unique transcriptional program
that is not regulated by cell cycle entry. Such quiescence
entry-speciﬁc genes may represent novel growth inhibitors
that link extracellular stimuli to the physiologic state of
quiescence.
In this report, we characterize the genomic expression
program of serum deprivation (SD) in ﬁbroblasts and identify
the predominance of asymmetric regulation in quiescence
induction. We identify two putative tumor suppressor genes,
SALL2 and MXI1, as key regulators of the serum deprivation
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the SDERGs in cell cycle exit and human cancer progression.
Results
Genomic Views of SS and SD Reveal That Early Response
Genes Are Asymmetrically Regulated
To understand the genomic program of entry into
quiescence, we characterized the temporal pattern of the
genome-wide transcriptional proﬁles of ﬁbroblasts in re-
sponse to SD. We employed the same diploid ﬁbroblast
culture and experimental time points that we previously used
to delineate a detailed transcriptional response to SS [7],
thereby enabling a systematic comparison of entry and exit of
quiescence. Human foreskin ﬁbroblasts were grown in media
containing 10% fetal bovine serum (FBS) for 48 hours, and
following switch to low serum media containing 0.1% FBS,
harvested at 15 time points ranging from 15 minutes to 48
hours after SD. Total RNA was extracted, ampliﬁed, and
hybridized along with human universal reference RNA onto
human cDNA microarrays containing ;43,000 elements,
representing ;23,000 unique genes.
Comparison of the temporal expression proﬁles of SD and
SS revealed two dynamic programs with marked asymmetry
in the early responses (Figure 1A). For each gene, we
quantiﬁed the similarity of its pattern of expression during
SD and SS by a Pearson correlation. (A correlation of  1
indicates exact opposite pattern; a correlation of 0 indicates
no relationship; a correlation of þ1 indicates identical
pattern.) Strikingly, genes with an induction or repression
onset after eight hours of treatment showed symmetric
regulation by SS and SD with a Pearson correlation of
 0.80 (i.e., genes induced by SS are repressed by SD and vice
versa). In contrast, genes regulated within the ﬁrst three
hours of SS or SD were asymmetrically governed by these two
stimuli (Pearson correlation  0.2 to þ0.2). Genes that were
regulated within three to eight hours of the treatments had
an intermediate level of symmetry. These results thus suggest
an asymmetric regulation of quiescence entry and exit with
distinct sets of early response genes.
To gain a higher order view of the transcriptional
programs of SS and SD, we next identiﬁed the functional
groups and upstream cis-regulatory sequences of genes that
are regulated in expression by these two stimuli (Figure 1B
and 1C). Using the module map method [14], we identiﬁed for
each array the coordinate induction or repression of 1,735
gene sets, each deﬁned as a group of genes encoding proteins
possessing a shared biological function, biochemical process,
or subcellular localization by gene ontology (p , 0.05; false
discovery rate [FDR] , 0.05) (Figure 1B) [15]. This higher
order view conﬁrmed that many functions known to be
regulated by serum [6], such as cell proliferation, RNA
metabolism, and sterol synthesis, are symmetrically regulated
by SS and SD in the late phase of each program (Figure 1B;
Figure S1). In contrast, while coordinate induction of genes
encoding transcription factors and signaling proteins char-
acterized the early response of SS, the genes that were
regulated in the early response of SD were enriched for
functions in immune response, redox, and extracellular
matrix metabolism (Figure 1B). The paucity of gene ontology
terms describing functional groups characterizing early SD
may reﬂect the current scarcity of knowledge about this
cellular state.
Transcriptional regulation is mediated in large part by
binding of trans-acting factors to cis-regulatory elements
upstream of genes. To better understand the regulation of SS
and SD, we therefore mapped the genome-wide occurrence
of 175 phylogenetically conserved cis-regulatory motifs [16] in
four kilobases surrounding transcriptional start sites ge-
nome-wide. For each array, we identiﬁed cis-regulatory motifs
that are signiﬁcantly enriched in the genes that are induced
or repressed, yielding a map of the regulatory motifs active in
quiescence entry and exit (Figure 1C). This unbiased
approach highlighted many known transcription factors that
play key roles in this process and again reveals the marked
asymmetry in the early response of SS and SD (Figure 1C). For
instance, the gene set deﬁned by enrichment of motifs for
E2F and DP transcription factors contained many cell cycle
genes and was symmetrically regulated late in the response by
SS and SD (Figure 1C; Figure S1). In contrast, gene sets
deﬁned by the motif of AP-1, MEF2, or NF-jB were induced
early in response to SS but were not substantially regulated by
SD. Once again, we noted a relative paucity of cis motifs that
identify early response genes to SD. This result may reﬂect
incomplete information of the relevant transcription factors
and their cognate cis motifs or may reﬂect additional post-
transcriptional mechanisms in regulating mRNA levels in SD.
SD Activates a Unique Gene Expression Program to
Induce Cellular Quiescence
To begin to understand the asymmetric regulation of
quiescence entry and exit, we focused on genes that are
induced early in response to either SS or SD. Approximately
half of the well-known early response genes to SS, such as
EGR1, CYR61, and GADD45B, were correspondingly repressed
by SD, albeit with lower amplitude and delayed kinetics that
peak at approximately three hours after SD (Figure 2A). In
contrast, other key SS early response genes, such as FOS,
JUNB, and MYC, are transiently induced by SS and showed
little change in transcript level in SD (Figure 2A). Conversely,
a group of 135 genes deﬁned by early induction in response
to SD, which we term SDERGs, showed immediate induction
within the ﬁrst three hours after SD, but demonstrated
substantially less or delayed regulation by SS (Figure 2B and
2C; Table S1). Some SDERGs, including SALL2, MXI1, and
TNKSBP1, are induced in a sustained manner by SD while
other SDERGs, such as SPRY4 and SMAD7, are induced by SD
in a transient manner. Intriguingly, SALL2 and MXI1 are both
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Author Summary
Cells constantly sense their environment to decide whether to
divide. Many genes that control the entry into cell division are
known, and their excessive activation may cause cancer. In contrast,
the way that cells cease to divide was thought to be a passive
process, where signals for cell division gradually decay. In this study,
the authors show that the decision to cease cell division and enter a
state termed quiescence is also an active process. By monitoring the
changes in activity over all genes, the authors identify a set of genes
that respond specifically to decrements of external stimuli and
ensure cessation of cell division. These genes act as brakes to
prevent excessive cell division, and their inactivity is characteristic in
many human cancers, particular those that progress to life threat-
ening disease.Figure 1. Systems Architecture of SS and SD in Human Fibroblasts
(A) Global transcriptional response of fibroblasts to SS and SD is presented. On the right a heat map of gene expression profiles is shown. Each column
is a time point; each row is a gene. Gene induction or repression relative to the zero time point of each time course is shown by the red-green intensity
according to the bottom scale. Gene clusters that are examined in Figure 2 are marked by black bars to the right. In the middle a temporal pattern of
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when overexpressed [17,18]. SALL2 encodes a zinc ﬁnger
transcription factor and is a homolog of Drosophila homeotic
gene Spalt. Human SALL2 resides in a chromosomal region
frequently deleted in ovarian cancers, and SALL2 protein is a
binding target of the oncogenic large T-antigen from
polyoma virus [19]. MXI1 is a member of the MAD family of
potent antagonists of MYC oncoproteins [20]. MXI1 resides
on a locus in human Chromosome 10 that is deleted in several
types of human cancers, including prostate cancer, and
deletion of MXI1 in mouse leads to a cancer-prone
phenotype [18]. We noted that several SDERGs are well-
known interferon-induced genes, such as STAT1, ILIR1,
BDKRB2, and PLSCR1; several additional SDERGs, such as
JUND, IFIT2, and G1P2 are predicted by our cis-regulatory
map to contain a motif for the interferon regulatory factor
(IRF) family of transcription factors. A likely candidate is
IRF1 because IRF1 can induce several of these genes, is itself
induced by SD, and possesses antiproliferative properties
[21,22]. The asymmetric regulation of early response genes
suggests that the transition to a quiescent state may be
enforced by employing signaling pathways unique to SD.
SALL2 and MXI1 Are for Cell Cycle Exit and Gene
Expression in Response to SD
To address the functional role of the SDERGs, we used
RNA interference to examine the requirement of speciﬁc
SDERGs for cell cycle exit. We selected four candidate genes
(SALL2, MXI1, IRF1, and TNKS1BP1) that encode tran-
scription factors or signaling proteins that may regulate
quiescence induction. TNKS1BP1, a putative telomere bind-
ing protein, was included because of the reported roles of
telomerase in enhancing S-phase progression [23,24]. We
transfected primary human foreskin ﬁbroblasts grown in high
serum (10% FBS) media with silent interfering RNA (siRNA)
pools corresponding to each of four candidate genes or a
control siRNA targeting GFP. The cells were switched to 0.1%
serum media 72 hours after transfection to induce quies-
cence, and DNA synthesis was measured 16 hours later by 5-
bromo-29-deoxyuridine (BrdU) incorporation. Reverse tran-
scription-PCR conﬁrmed decreased expression of the target
mRNAs (Figure S2). In control cells treated with siRNAs
targeting GFP, SD lowered the percentage of BrdUþ cells
from 65% to approximately 25%, indicating induction of
quiescence and efﬁcient cell cycle exit (Figure 3A and 3B).
Strikingly, cells treated with siRNAs targeting SALL2 doubled
the number of BrdUþ cells after SD (p , 0.0001), while
siRNAs targeting MXI1 showed modest but consistent
increase in BrdUþ cells (p , 0.02). siRNAs to IRF1 or
TNKS1BP1 did not signiﬁcantly affect quiescence induction
under the conditions tested. To test the potential functional
relationships between SALL2, MXI1, and IRF1, we treated
cells with pair-wise combinations of siRNAs. Silencing of
IRF1 strongly cooperated with silencing of MXI1, but
silencing of neither IRF1 or MXI1 cooperated with silencing
of SALL2 to prevent cell cycle exit. Fluorescence-activated
cell sorting analysis of DNA content conﬁrmed that depletion
of SALL2 or MXI1 blocked the ability of cells to arrest in G0–
G1 after growth factor deprivation and instead led to
inappropriate progression through S and G2/M phases of
the cell cycle (Figure 3C). These results suggest that several of
the SDERGs identiﬁed by our microarray screen are required
for entry to cellular quiescence and that SALL2 and MXI1
may trigger different pathways to enforce quiescence.
To further delineate the mechanisms of SALL2 and MXI1
action, we identiﬁed genes that required SALL2 and MXI1 for
proper regulation during quiescence induction. RNA from
cells transfected with silent interfering (si)SALL2 and siMXI1
was extracted, ampliﬁed, and compared with RNA from cells
treated with siGFP on cDNA microarrays.
Genes whose expression levels were consistently changed
by loss of SALL2 or MXI1 were identiﬁed, and their temporal
regulation by SS and SD were systematically organized by
hierarchical clustering. We observed three main patterns of
gene regulation. First, both SALL2 and MXI1 are individually
required for the induction of a cluster of SD middle response
genes (Figure 4, cluster 1). After knockdown of either SALL2
or MXI1 in SD, these genes reverted to a pattern of
expression more closely resembling their normal behavior
in SS than in SD. Second, in contrast to this shared role in SD
gene induction, SALL2 and MXI1 acted to repress mutually
exclusive sets of SD-repressed genes (Figure 4, cluster 3).
Third, SALL2 appears to have a unique role in limiting
expression of a set of middle response genes to SD, as their
expression became super-induced when SALL2 was silenced
(Figure 4, cluster 2). These results conﬁrm the distinct roles of
SALL2 and MXI1 in quiescence induction and suggest
multiple roles for SALL2 in gene regulation throughout
quiescence entry and maintenance.
Widespread Repression of SDERGs in Human Cancers
Having discovered the SDERGs as a set of 135 genes
speciﬁcally induced when ﬁbroblasts enter quiescence, we
next tested whether the SDERGs might have broad roles in
growth inhibition. We reasoned that if SDERGs were
generally required to induce cell quiescence, then SDERGs
might be coordinately repressed in conditions of excessive
cell proliferation, such as in cancer. We therefore interro-
gated a compendium of 1,973 microarrays representing 22
human tumor types to search for enriched coregulation of
the 135 SDERGs, using the gene module map method [14].
The SDERGs were indeed coordinately repressed in many
conditions that represent pathologic proliferation, speciﬁ-
cally the subset of fast doubling cell lines in the NCI60
gene regulation is shown. For each gene cluster, the onset of gene induction or repression in the SS or SD time courses is indicated by E, M, or L. Note
the strong asymmetry of regulation in the early (E) (,3 h) time points, which gradually converge in the middle (M) (3–8 h) time points, and demonstrate
symmetric regulation in the late (L) (.8 h) time points. On the left the Pearson correlation of gene expression profile in SS versus that of SD is
presented. The average correlation value of ten nearest genes as grouped by hierarchical clustering is shown.
(B) Module map of enriched gene ontology functions in the transcriptional programs of SS and SD is presented. Each column is a time point; each row is
an enriched gene ontology term (p , 0.05; FDR , 0.05). For each gene ontology term, the average expression of the enriched member genes is shown
by color intensity according to the scale bar. Select themes of gene ontology functions are highlighted on the left.
(C) Module map of enriched cis-regulatory motifs in the transcriptional programs of SS and SD is presented. Functional groups and cis motifs based on
the same underlying sets of genes are indicated by matching colors of solid bars and text on the left of (B) and (C), respectively.
doi:10.1371/journal.pgen.0030091.g001
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The transcriptional pattern, enriched gene ontology functions, and enriched cis motifs of early response genes to SS and SD.
(A) Early response genes showing induction in SS are unresponsive or weakly responsive in SD.
(B) Most early response genes showing induction in SD are not regulated in SS.
(C) Some early response genes in SD show immediate induction followed by repression. The genes in (B) and (C) are collectively defined as the SDERGs.
doi:10.1371/journal.pgen.0030091.g002
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Quiescence Entry Genescollection of tumor cell lines (p , 10
 10) and several human
cancers relative to their normal tissue counterpart including
cancers of prostate (p , 10
 6), blood (p , 10
 12), and lung (p
, 10
 4) (Figure 5A). These results suggest that SDERGs likely
antagonize cell proliferation in many cell types.
Cancer consists of a broad range of clinical behaviors
ranging from indolent tumors to aggressive metastatic
disease. To further dissect the potential molecular variation
underlying this clinical heterogeneity and to extend and
validate our results, we tested the prognostic power of the
SDERG gene set in independent datasets and different
subtypes of human cancer. Analyzing DNA microarray data
from a study of 103 prostate tissues and cancer [25], we found
that coordinate repression of SDERGs could identify over
90% of prostate tumors relative to normal prostate, a ﬁnding
very unlikely due to chance alone (p , 10
 11) (Figure 5B).
Furthermore, expression of SDERGs in a set of 295 breast
cancers [26] naturally divided the breast tumors into two
groups (Figure 5C). Patients with breast cancers that
diminished expression of SDERGs had signiﬁcantly worse
survival (p , 10
 5) and signiﬁcantly increased probability of
metastasis (p , 10
 4). This group of tumors with repression of
SDERGs also tended to be of the grade 3 tumors (p , 10
 9),
which are deﬁned by higher cell proliferation and less
differentiation. Interestingly, the mRNA levels of SALL2
and MXI1, either alone or in combination, were insufﬁcient
to predict overall survival or metastasis-free survival (p .
0.05, Cox-Mantel test); conversely, removal of SALL2 and
MXI1 from SDERGs did not affect the prognostic power of
the SDERG gene set (unpublished data). These results further
Figure 3. Two SDERGs, SALL2 and MXI1, Are Required for Cell Cycle Exit in Response to SD
(A) SALL2 and MXI1 are required for cell cycle exit. Percentage of BrdU-positive cells with SD and with treatment of the indicated siRNAs are shown
(mean 6 standard error). *, p , 0.05 compared to the effect of siGFP by Student’s t-test. **, p , 0.05 compared to the strongest effect of the single
gene knockdown.
(B) Immunofluorescence of BrdU incorporation for cells treated with siGFP, siSALL2, and siMXI1 is shown.
(C) The upper panel shows cell cycle profiles of cells with the indicated treatments as determined by FACS analysis. PI, propidium iodide staining. The
lower panel shows quantification of four replicates (average 6 standard error) of the indicated cell cycle stages.
doi:10.1371/journal.pgen.0030091.g003
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pathologic proliferation. By reﬂecting the propensity for
quiescence, the expression level of the SDERG gene set as
whole may aid in predicting tumor behavior in two of the
most common human cancers.
Quiescence Initiation versus Quiescence Maintenance
To better understand the transcriptional regulation of
quiescence initiation versus maintenance, we compared
SDERGs (135 genes) with 116 genes previously found to be
concordantly induced by prolonged entry into quiescence,
four days after growth factor deprivation, contact inhibition,
or loss of adhesion [4]. A total of nine genes were in common
between these two gene sets, while only one overlap gene is
expected by chance alone (p , 10
 7,h y p e r g e o m e t r i c
distribution). The overlap genes include MXI1 and STAT1,
thus indicating an interesting but limited overlap between
the SDERGs and genes expressed during quiescence main-
tenance (Figure 6A). We next examined the coordinate
expression of these 116 quiescence maintenance genes in
1,973 microarray representing 22 human tumor types (Figure
6B). SDERGs and quiescence maintenance genes showed
overlapping but distinct patterns of expression, with some
tumors coordinately repressing both gene sets but many that
repress only one of the two sets. In human prostate cancer,
quiescence maintenance genes are typically repressed but in
far more haphazard fashion compared to SDERGs (p value of
the separation is ﬁve logs of magnitude worse) (Figure 6C).
Similarly, coordinate repression of quiescence maintenance
genes is modestly predictive of primary breast cancer survival
but not predictive of metastasis-free survival (Figure 6D and
unpublished data). These results suggest that genes mediating
entry into quiescence are largely distinct from those
associated with quiescence maintenance, and the two
programs may be repressed in distinct fashions to facilitate
the progression of speciﬁc types of human cancers.
SDERG Induction Is Distinct from Stress Response
The general association between SDERGs and cell cycle exit
raises the possibility that SDERGs may be induced by
additional stimuli. For instance, in response to variety of
noxious stress, cells will exit the cell cycle as part of the stress
response. To test the possibility that SDERGs may be induced
by stress, we queried the expression pattern of SDERGs in the
published gene expression data of ﬁbroblasts exposed to
multiple types of stress [27]. In contrast to the strong
induction of SDERGs by SD, exposure of ﬁbroblasts to the
reducing agent dithiothreitol (causing protein unfolding and
endoplasmic reticulum stress), heat shock, or menadione
(inducing oxidative stress) did not induce the SDERGs (Figure
7A). These results reafﬁrm SDERGs as a program uniquely
responsive to loss of growth factor signaling as represented by
SD.
Discussion
Asymmetric Regulation of Quiescence Entry and Exit
By determining the genomic transcriptional program in
response to SS and SD, we observed the asymmetric
regulation of quiescence entry and exit (Figure 1). While
Figure 4. SALL2 and MXI1 Are Differentially Required for Gene Regulation in SD
On the right, altered global transcriptional programs are shown 16 h after SD by transfection with siSALL2 or siMXI1, each compared against siGFP
reference RNA and performed in duplicates. Red indicates higher expression in cells treated with siSALL2 or siMXI1 compared to cells treated with siGFP;
green indicates the lower expression in siSALL2 or siMXI1 samples versus siGFP.
On the left, the temporal expression program of the same genes SS and SD is shown. The genes are grouped by their similarity of expression by
hierarchical clustering; the three clusters indicated on the far left are as described in the text.
doi:10.1371/journal.pgen.0030091.g004
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(A) SDERGs are coordinately repressed in highly proliferative cells and human cancers. We interrogated a compendium of 1,973 microarrays
representing 22 human tumor types and diverse normal controls for coordinate regulation of the SDERGs. In the heat map displayed, each column is a
sample showing coordinate induction or repression of SDERGs (p , 0.05, FDR , 0.05, hypergeometric distribution); each row is a SDERG. In the top
matrix enriched clinical annotations of microarrays show SDERG repression. Each microarray in the compendium was annotated with biological and
clinical information of the sample; we therefore queried each annotation for enrichment of SDERG induction or repression. Each blue hatchmark
indicates a sample with the indicated annotation. Each row is an enriched annotation (p , 0.05, FDR , 0.05). A total of four examples in the top ten
enrichments are shown.
(B) Repression of SDERGs distinguish prostate cancer from normal prostate in an independent dataset of 103 samples [25] (p , 10
 11, chi-square test).
(C) Repression of SDERGs in human breast cancer predicts increased metastasis and poor survival. In the upper panel hierarchical clustering with
SDERGs separate 295 stage I and II early breast tumors into two groups, with predominant induction or repression of SDERGs. In the lower panel
Kaplan-Meier survival curves show worse survival (p , 10
 5) and increased metastasis (p , 10
 4) of patients with tumors that repressed SDERGs.
doi:10.1371/journal.pgen.0030091.g005
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stimuli are largely symmetric, this symmetric program results
from two distinct early transcriptional responses. These data
suggest that in addition to previously identiﬁed antiprolifer-
ative genes that require ongoing growth factor signaling for
their suppression [10], a major mechanism of quiescence
entry is the induction of a set of unique quiescence entry
genes (Figure 2). By simple analogy, a speeding car may be
slowed by releasing the gas pedal, but the car can also be
brought to a screeching halt by releasing the gas pedal and
stepping on the brakes. We suggest that the SDERGs may be a
set of brakes for cell cycle progression and growth factor-
induced gene expression. Just as a gain of growth factor
signaling activates the classic immediate early genes to induce
cell cycle entry, a loss of growth factor signaling uniquely
activates the SDERGs to induce cell quiescence. The decision
of cell proliferation or quiescence is thus determined by the
balance of growth factor-induced genes and SDERGs (Figure
7B). SDERGs are also actively involved in the repression of
growth factor-induced genes. For instance, SALL2 and MXI1
are required to repress distinct sets of serum-inducible genes
(Figure 3C); in the case of MXI1 this may occur by direct
competition with MYC for binding to promoters of serum-
inducible genes [20]. Thus, there is likely cross regulation of
the early transcriptional responses to growth factor stimula-
tion and deprivation.
Figure 6. Comparison of SDERGs with Genes Associated with Quiescence
Maintenance
(A) Overlap of SDERGs with 116 quiescence maintenance genes defined
by Coller et al. [4] is shown.
(B) Comparison of coordinate regulation of SDERG or 116 quiescence
maintenance genes in human cancers is presented. Shown are select
enriched clinical annotations in the subset of 1,973 microarrays
representing 22 human tumor types where the gene set of interest is
coordinately repressed (p , 0.05; FDR , 0.05). One exception is the
induction of quiescence maintenance genes in the slow doubling subset
of the NCI60 cell lines.
(C) Repression of SDERG versus quiescence maintenance genes in
prostate cancer relative to normal prostate tissue is presented. Shown is
the negative log of the p value of the concordance of gene expression
compared to that expected from chance alone (chi-square test).
(D) Modest prognostic power of the 107 unique quiescence maintenance
genes for predicting overall survival in primary human breast cancers is
presented.
doi:10.1371/journal.pgen.0030091.g006
Figure 7. SDERGs Are Unique Responders to Growth Factor Deprivation
(A) SDERGs are not induced by diverse cell stress. Comparison of heat
map and average expression levels of SDERGS in response to SD,
dithiothreitol, heat, and methadione is presented.
(B) Models of entry into cell quiescence are presented. In Model 1, cells
interpret gain and loss of growth factor signaling by one set of common
genes, leading to a decision to engage proliferation or quiescence.
Quiescence can be just the absence of positive signals for proliferation.
In contrast, Model 2 incorporates the discovery of SDERGs as a
transcriptional program uniquely responsive to loss of growth factor
signaling and mediates quiescence entry. Two distinct sets of early
response genes actively signal the gain and loss of growth factor
signaling, the balance of these two transcriptional programs determines
proliferation versus quiescence.
doi:10.1371/journal.pgen.0030091.g007
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to growth factor gain and loss is to achieve tight regulation. It
has been well known that many early response genes to SS
are induced as a precise pulse that then rapidly decays
despite continued mitogen presence (Figure 2A), thereby
providing a check against unlimited proliferation and the
risk of cancer. For instance, the classic mitogen-induced
proto-oncogene MYC is regulated by transcriptional autor-
epression [28], mRNA instability [29], and rapid protein
turnover [30,31]; enforced MYC expression is sufﬁcient to
induce ectopic DNA replication and DNA damage within just
one cell cycle [32]. The low level of MYC and other growth
factor early response genes at steady state would render a
system based on their further decrement an insensitive
strategy to detect growth factor deprivation. Instead, a
decrement of growth factor signaling triggers a robust
transcriptional response of SDERGs, leading to additional
quiescence gene induction and exit of cell cycle. Intriguingly,
a large number of SDERGs (including SALL2 and MXI1,
which are required for entry to quiescence) are induced and
maintained in stable expression in response to SD (Figure
2B). The longevity of SDERG expression in contrast to the
transient expression of growth factor early response genes
may provide an explanation for cell quiescence as the default
state of most eukaryotic cells.
SALL2 as a Mediator of Cell Quiescence
Among the several the SDERGs we tested, silencing of
SALL2 expression had the most substantial effect on cell cycle
exit in response to growth factor deprivation. Previously,
Benjamin and colleagues had identiﬁed SALL2 as an
antiproliferative gene by virtue of a tumor host range
selection procedure for the oncogenic polyoma virus [19].
Enforced SALL2 expression in ovarian cancer cells inhibits
tumor xenograft growth in vivo and can induce the
expression of cyclin-dependent kinase inhibitor p21,
although it is unclear whether p21 is the sole mechanism by
which SALL2 elicits cell cycle arrest [17]. The biological
context in which SALL2 might exert its antiproliferative
effect was also not known. Our results suggest that SALL2 is
induced in response to loss of growth factor signaling (Figure
2B). Acute loss of SALL2 during SD blocked the ability to stop
DNA synthesis and induce additional quiescence-associated
genes, suggesting that SALL2 is required for quiescence
induction in response to growth factor deprivation (Figure
3C). Among the mammalian SALL family of zinc ﬁnger
transcription factors, mutation of SALL1 leads to devel-
opmental abnormalities [33], and SALL4 is required for
maintenance of pluripotency in embryonic stem cells [34,35].
Surprisingly, SALL2 knockout mice are viable and have no
obvious phenotype [36], raising the possibility that SALL2’s
function may be redundant or compensated by other SALL
family members. Indeed, we found that knockdown of SALL4
also blocks cessation of DNA synthesis in response to SD even
though SALL4 mRNA level does not change in response to SD
(H. Liu and H. Y. Chang, unpublished data). Thus, it may be
the total pool of SALL transcription factors in the cell that
determines cell quiescence, and SALL4 may compensate for
the chronic loss of SALL2 during development. Coller et al.
have shown that quiescence in ﬁbroblasts inhibits their trans-
differentiation (such as into muscle cells in response to
enforced MyoD expression) [4]; the role of SALL tran-
scription factors in cell quiescence may therefore be
intimately linked to their roles in stem cell pluripotency
[34,35]. The mechanisms by which the SALL2 message
accumulates during SD and the functional roles of newly
discovered SALL-regulated genes in SD should be addressed
in future studies.
Repression of SDERGs in Human Cancer
Because cell quiescence has been postulated to be an
important safeguard against cancer [1], we reasoned that a
transcriptional program mediating entry into quiescence
might be systematically repressed in human cancers. Our
survey of nearly 2,000 microarrays representing diverse types
of human cancers identiﬁed multiple tumor types in which
SDERGs are coordinately repressed (Figure 4). In addition, we
found that repression of SDERGs unambiguously distin-
guished prostate cancers from adjacent prostate tissues, and
repression of SDERGs in human breast cancers further
predicted aggressive clinical course of early stage tumors.
These properties are speciﬁc to SDERGs and are present to a
much lower extent in genes associated with quiescence
maintenance (Figure 6). Combined with the evidence that
several SDERGs are required for cell cycle exit, these results
highlight a potentially important role for the ability of cells to
sense decrements of growth factor signaling and respond by
quiescence. SDERGs and other genes induced by stimuli that
induce cell quiescence may represent previously unrecog-
nized tumor suppressor pathways; better understanding of
these transcriptional programs may lead to new avenues of
cancer diagnosis and treatment.
Materials and Methods
Cell and tissue culture. Primary human foreskin ﬁbroblasts (CRL
2091; American Type Culture Collection, http://www.atcc.org) were
cultured in DMEM plus 10% FBS. Cells were plated at 10%
conﬂuence. Cells were switch to DMEM plus 0.1% FBS 48 h after
the last passage and harvested at the indicated time points.
Microarray procedures. Construction of human cDNA microarrays
containing approximately 43,000 elements, representing approxi-
mately 23,000 different genes, and array hybridizations were as
previously described [8]. Total RNA was extracted using Trizol
according to the manufacturer’s instructions (Invitrogen, http://www.
invitrogen.com) and ampliﬁed using the Ambion MessageAmpII
aRNA kit (Ambion, http://www.ambion.com). For time course experi-
ments, Human Universal Reference RNA (Stratagene, http://www.
stratagene.com) was used as reference RNA to compare with RNA
from individual time points. We took four independent samples at
time zero, which functioned as the baseline for other sample time
points. For siRNA samples, siGFP was used as the reference RNA to
compare with RNA from cells transfected with siSALL2 or siMXI1;
each comparison was performed in duplicate. Full microarray data
are available for download at Stanford Microarray Database (http://
genome-www5.stanford.edu) or Gene Expression Omnibus (http://
www.ncbi.nlm.nih.gov/geo).
Data analysis. We selected genes for which the corresponding array
elements had ﬂuorescent hybridization signals at least 1.5-fold
greater than the local background ﬂuorescence in the reference
channel and further selected genes for which technically adequate
measurements were obtained from at least 80% of the samples in a
given dataset. The zero time point for the SD experiment was
performed in quadruplicate, and the four gene expression measure-
ments were averaged and subtracted from those of the subsequent
time points in order to visualize gene induction or repression over
time. The gene expression proﬁles of the same cells to SS over 15 time
points were similarly transformed by subtraction of expression value
from each time point by that of the zero time point. The two datasets
were then merged by matching Stanford clone IDs of the cDNA
probes. We next focused on genes that exhibited substantial variation
in expression and selected the subset of genes that were induced or
repressed by at least four-fold in at least one array in either time
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were organized and grouped based on the similarity in their patterns
of expression by average linkage clustering using the Cluster software
[37]. Clustering of genes revealed three main transition points of gene
expression variation—immediately after SS or SD, three hours after
the stimuli, or eight hours after the stimuli. We therefore deﬁned a
time for the induction or repression of each gene cluster as the time
point at which the gene expression reaches half maximal induction or
repression, and classiﬁed each cluster as being regulated early (,3 h),
middle (3–8 h), and late (.8 h). For gene clusters that exhibit biphasic
or more complex patterns of regulation, we deﬁned the onset of
activity based on the ﬁrst peak of expression variation. To quantify
the degree of divergence among early-, mid-, and late-response genes,
we calculated the Pearson correlation between the expression pattern
of the SS and SD time courses for each gene. After ordering genes by
hierarchical clustering, we visualized the Pearson correlation of gene
clusters by displaying the moving average of correlation values of the
ten nearest genes along the y-axis of the heat map.
The gene module map of functional groups of genes was as
described using the software package Genomica [14]. Brieﬂy, for each
microarray, we identiﬁed genes that were induced or repressed by at
least 2-fold and tested for their enrichment in each of 1,735 gene sets
deﬁned by gene ontology terms [15] using the hypergeometric
distribution. An FDR calculation was used to account for multiple
hypothesis testing. Enrichments that had p , 0.05 and FDR , 0.05
were considered signiﬁcant and are shown in Figure 1B, yielding a
higher order view of each gene expression proﬁle as sets of activated
and repressed functions.
For the cis-regulatory motif map, we ﬁrst deﬁned motif modules
from the data of Xie et al. [16], where each motif module is a group of
genes that shared enrichment in an evolutionarily conserved cis-
regulatory motif in their upstream regulatory sequences. The
upstream regulatory region of each gene is deﬁned as the 4,000 base
pairs centered at the annotated transcription start site, as was done
by Xie et al.; 175 motif modules were deﬁned. Second, for each array,
we identiﬁed genes that were induced or repressed by 2-fold and
tested for their enrichment in each of the motif modules using the
hypergeometric distribution as described above. Modules with
signiﬁcant enrichment (p   0.05) were identiﬁed and shown in
Figure 1C, yielding a higher level view of each expression proﬁle as a
combination of activated and repressed cis-regulatory motifs.
To conduct microarray analysis of siRNA treated cells we
employed a type I microarray design where mRNA of cells treated
with siSALL2 or siMXI1 (labeled with Cy5) was compared to mRNA of
cells treated with siGFP (labeled with Cy3) by competitive hybrid-
ization to cDNA microarrays. We selected for analysis genes for which
the corresponding array elements had ﬂuorescent hybridization
signals at least 1.5-fold greater than the local background ﬂuores-
cence in the reference channel, and we further restricted our analyses
to genes for which technically adequate measurements were obtained
from both duplicate arrays. We further selected genes that were
induced or repressed by at least 2-fold in two arrays by siSALL2 or
siMXI1, and the genes were organized by average linkage clustering.
Regarding the cancer compendium and clinical outcome data, a
cancer compendium of 1,973 microarrays was as described [14]. Gene
probes from different microarray platforms were mapped by
LocusLink identiﬁcation numbers ((http://www.ncbi.nlm.nih.gov/
entrez/query.fcgi?db¼gene). To test for the coordinate regulation of
SDERGs in human cancers, we deﬁned the 135 SDERGs as one gene
set and tested each expression proﬁle in the compendium for
coordinate induction or repression of the SDERGs using the module
map method in Genomica [14]. Speciﬁcally, for each microarray, we
identiﬁed genes that were induced or repressed by at least 2-fold, and
tested for their enrichment in SDERGs over that expected by chance
alone (p , 0.05, FDR , 0.05). Next, to identify enriched clinical
annotations among samples that exhibit coordinate SDERG induc-
tion or repression, for each annotation we compared the frequency
of SDERG induction or repression among the samples versus that
expected by chance alone. We found many signiﬁcant enriched
annotations of SDERG repression but not of SDERG induction in
cancer (p , 0.05, FDR , 0.05, hypergeometric distribution). Several
of the top ten enriched clinical annotations are reported in Figure
5A. The exact same procedure was repeated for 116 quiescence
maintenance genes deﬁned by Coller et al. [4].
To examine the expression of SDERGS in an independent set of
human prostate cancer, we used the published prostate cancer
microarray data of Lapointe et al. [25]. Gene probes were matched by
cDNA clone IDs as this dataset was also generated on Stanford cDNA
microarrays. We computed the average expression value of the 135
SDERGs in each of the 103 samples and rank ordered the average
SDERG expression values. We considered those samples with average
SDERG expression value greater than the mean of all 103 samples to
have induction of SDERGs and those samples with average SDERG
expression value to be below the mean of all 103 samples to have
repression of SDERGs. The signiﬁcance of the observed grouping of
over 90 percent of prostate cancers with repression of SDERGs
compared to normal prostate was evaluated by a two-by-two chi-
square test, yielding a p value of 10
 11. p Values were also calculated
using the same procedure for the 116 quiescence maintenance genes
and the 107 genes unique to Coller et al. [4] and plotted in Figure 6C
as the  log10(p value).
To examine the clinical signiﬁcance of SDERG repression in
human breast cancer, we used the published breast cancer microarray
data of van de Vijver et al. [26]. Gene probes were matched by
Unigene ID (http://www.sgn.cornell.edu/bulk/input.pl?mode¼unigene),
and the 295 breast cancer samples were organized by two-way
hierarchical clustering based on the expression pattern of the
SDERGs. The main bifurcation of the dendrogram separated the
breast cancer samples into two groups, one group with coordinate
induction of SDERGs (termed ‘‘SDERG up’’) and one group with
coordinate repression of SDERGs (termed ‘‘SDERG down’’). We
compared the differences in overall survival and metastasis-free
survival of these two groups of patients as deﬁned by SDERGs using
the Cox–Mantel test in the program Winstat (R. Fitch Software, http://
www.winstat.com). Data from the 295 breast cancer samples were
obtained for the quiescence maintenance genes unique to Coller et
al. [4] and the same procedures as described above were performed.
To examine the expression pattern of SDERGs in ﬁbroblasts
undergoing cell stress, we downloaded the published microarray data
of Murray et al. [27]. Gene probes were matched by Stanford cDNA
clone IDs. Expression of SDERGs during SD or exposure to DTT,
heat, or menadione are shown as heat maps, and the average
expression values are shown across each time course as a graph in
Figure 5A.
RNA interference and cell cycle analysis. Cells were transfected
with 20 nM of siRNA pools corresponding to each of the target genes
(SALL2, MXI1, IRF1, and TNKS1BP1) and a control (siGFP) using
DharmaFECT3 according to the manufacturer’s instructions (Dhar-
macon, http://www.dharmacon.com). Fibroblasts were transfected
with 20 nM of siRNAs at a density of 2310
5 cells/well (six-well plate)
in high serum (10% FBS) media. After 24 h, the treated ﬁbroblasts
were replated at a density of 6 3 10
3 cells/well in four-well chamber
slides and were allowed to recover in high serum for 48 h. The
transfected cells were then transferred to low serum (0.1% FBS)
media for 16 h. The transfection efﬁciency of each siRNA was veriﬁed
by qRT-PCR (Figure S1). DNA synthesis was monitored by measuring
the incorporation of the thymidine nucleotide analog BrdU (Sigma,
http://www.sigmaaldrich.com) into DNA as previously described [11].
Brieﬂy, cells were incubated with 10 lM BrdU in the media for 6 h;
then washed with PBS, ﬁxed, and stained with an anti-BrdU
monoclonal antibody (Becton Dickinson, http://www.bd.com) and
Alexa Fluor-conjugated goat anti-mouse antibody (Molecular Probes,
http://www.invitrogen.com). The percentage of BrdU-positive cells
among .200 DAPI-positive cells in four random ﬁelds was recorded.
Propidium iodide staining of DNA content and FACS analysis were
performed as described [38], with four replicate samples for each
condition.
Quantitative Reverse Transription-PCR. Gene expression levels
for genes targeted by the siRNAs were quantitated using RNA
extracted from the transfected cells by Taqman quantitative one-step
RT-PCR (Applied Biosystems, http://www.appliedbiosystems.com).
Taqman probes to SALL2, MXI1, and IRF1 were used. Assays were
normalized to GAPDH levels, and relative abundance was calculated
using a delta–delta threshold analysis as previously described [39].
The assay identiﬁcation numbers for the Taqman probes are in the
Accession Numbers list in the Supporting Information section of this
paper.
Supporting Information
Figure S1. Late Response Genes to SS and SD Show Symmetric
Regulation
Induction of cell cycle genes by SS and their coordinate repression by
SD is shown. Our module map method identiﬁed two well-known cell
cycle regulators—the joint motif of E2F:DP complexes as well as the
motif for NFY—as enriched cis-regulatory sequences for these genes.
Conversely, genes involved in sterol metabolism are repressed by SS
(because of the presence of cholesterol in serum) and coordinately
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Quiescence Entry Genesinduced by SD. Our method also correctly identiﬁed the known key
regulator, SREBP, by its enriched cis-regulatory motif.
Found at doi:10.1371/journal.pgen.0030091.sg001 (271 KB PDF).
Figure S2. Efﬁciency of siRNA Knockdown as Veriﬁed by Quantita-
tive Reverse Transcription-PCR
Relative mRNA levels (mean 6 standard error) are shown. We
compared the level of siRNA-mediated inhibition of gene expression
in quiescent cells relative to the baseline level in asynchronously
growing cells. The degrees of siRNA-mediated inhibition are 64%
knockdown for SALL2, 100% knockdown for MXI1, and 48%
knockdown for IRF1.
Found at doi:10.1371/journal.pgen.0030091.sg002 (30 KB PDF).
Table S1. SDERGs
Listed are the SDERGs, which showed immediate induction within
the ﬁrst three hours after SD but demonstrated substantially less or
delayed regulation by SS.
Found at doi:10.1371/journal.pgen.0030091.st001 (12 KB PDF).
Accession Numbers
The LocusLink (http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?db¼gene) and Unigene ID (http://www.sgn.cornell.edu/bulk/
input.pl?mode¼unigene) of genes discussed in this manuscript are
listed in Table S1.
The National Center for Biotechnology (NCBI) Probe Database
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db¼probe) accession
numbers for the Taqman probes discussed in this manuscript are
GAPDH, Hs99999905_m1; IRF1, Hs00233698_m1; MXI1,
Hs00365651_m1; and SALL2, Hs00826674_m1.
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